Waiving the vaccine patent may depend on incentives

Name: Waiving the vaccine patent may depend on incentives
Uploaded: 2021-05-06T21:24:00Z
Duration: P404S
Description: President Joe Biden has given the initial nod for the U.S. to waive patent rights on COVID vaccines to boost international production. But there are real questions over how effective these moves would be, what other countries feel about it, and when this would translate into action. William Brangham discusses the matter with Rachel Silverman, a policy fellow at the Center for Global Development.

Clip: 05/06/2021 | 6m 44s | Video has closed captioning.

President Joe Biden has given the initial nod for the U.S. to waive patent rights on COVID vaccines to boost international production. But there are real questions over how effective these moves would be, what other countries feel about it, and when this would translate into action. William Brangham discusses the matter with Rachel Silverman, a policy fellow at the Center for Global Development.

Aired: 05/06/21

Rating: NR

Problems Playing Video? | Closed Captioning

Major corporate funding for the PBS NewsHour is provided by BDO, BNSF, Consumer Cellular, American Cruise Lines, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Consumer …

Major corporate funding for the PBS NewsHour is provided by BDO, BNSF, Consumer Cellular, American Cruise Lines, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Consumer Cellular and American Cruise Lines. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.

Waiving the vaccine patent may depend on incentives

More News and Public Affairs Shows